<?xml version="1.0" encoding="UTF-8"?>
<p>Preliminary studies evaluating the extract of 
 <italic>C. articulatus</italic> also identified elevated concentration of corymbolone among all the other identified substances and showed in vitro antiplasmodial activity [
 <xref rid="B25-pathogens-09-00889" ref-type="bibr">25</xref>]. Considering the verified antiplasmodial action and the low toxicity of this molecule, it may has potential to be used as an alternative of chloroquine, which has adverse effects [
 <xref rid="B26-pathogens-09-00889" ref-type="bibr">26</xref>,
 <xref rid="B27-pathogens-09-00889" ref-type="bibr">27</xref>]. Alpha-bulnesene has biological activity related to the inhibition of platelet activation factor [
 <xref rid="B28-pathogens-09-00889" ref-type="bibr">28</xref>]. Toxicity analysis, which is necessary when investigating the biological activity of products with potential for phytotherapy, is conducted with the objective of determining the potential of new substances and products without causing risk to human health and classifying them according to their potential for lethality or toxicity as established by legislation [
 <xref rid="B29-pathogens-09-00889" ref-type="bibr">29</xref>].
</p>
